Innovent Biologics Inc.
IVBXF | OTC
$9.90
-$1.40 (-12.39%)
At close: Oct 30, 2026, 2:35 PM ET
$9.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | 838.92M | -78.62M | -1.14B | -2.17B | -2.73B | -858.71M |
Depreciation & Amortization | 601.32M | 419.77M | 385.1M | 319.42M | 204.75M | 85.63M |
Stock-Based Compensation | 662.7M | 556.52M | 574.2M | 469.49M | 501.57M | 402.5M |
Other Working Capital | 8.93B | 401.64M | 475.07M | -29.63M | 551.3M | -22.63M |
Other Non-Cash Items | -46.47M | -14.4M | -70.47M | -847.16M | 37.49M | -5.34M |
Deferred Income Tax | n/a | n/a | n/a | n/a | 50.39M | 402.3M |
Change in Working Capital | 7.94B | 403.76M | 403.39M | 309.91M | -90.28M | -334.06M |
Operating Cash Flow | 10B | 1.29B | 147.81M | -1.92B | -2.02B | -307.69M |
Capital Expenditures | -683.27M | -1.71B | -1.38B | -1.38B | -1.85B | -771.78M |
Cash Acquisitions | n/a | -900M | n/a | n/a | -630.14M | 88.71M |
Purchase of Investments | -21.11B | -10.54B | -9.41B | -10.33B | -10.34B | -11.64B |
Sales Maturities Of Investments | 14.74B | 10.47B | 9.24B | 10.02B | 10.12B | 7.16B |
Other Investing Acitivies | 134.92M | 833.89M | 290.87M | 252.4M | -4.08M | -17.22M |
Investing Cash Flow | -6.51B | -1.17B | -998.66M | -1.44B | -2.7B | -5.18B |
Debt Repayment | -38.68M | -704.48M | 418.5M | 715.17M | 1.21B | 355.18M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 48.4M | 13.53M | -86.36M | 45.85M | -155.24M | -105.42M |
Financial Cash Flow | 4.73B | -606.63M | 2.59B | 2.89B | 5B | 4.91B |
Net Cash Flow | 8.1B | -472.34M | 1.73B | -343.24M | 83.23M | -1.15B |
Free Cash Flow | 9.32B | -418.39M | -1.24B | -3.3B | -3.87B | -1.08B |
Adj. Free Cash Flow | 8.66B | -974.91M | -1.81B | -3.77B | -4.37B | -1.48B |
Maintenance CapEx | n/a | n/a | n/a | -1.09B | -1.39B | n/a |
Growth CapEx | -683.27M | -1.71B | -1.38B | -288.68M | -453.3M | -771.78M |
Owner Earnings | 10B | 1.29B | 147.81M | -3.01B | -3.42B | -307.69M |
Add to Watchlist
Select watchlists to add or remove IVBXF